These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32200655)

  • 1. Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen.
    Deplano A; Karlsson J; Svensson M; Moraca F; Catalanotti B; Fowler CJ; Onnis V
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):815-823. PubMed ID: 32200655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and
    Deplano A; Karlsson J; Moraca F; Svensson M; Cristiano C; Morgillo CM; Fowler CJ; Russo R; Catalanotti B; Onnis V
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):940-953. PubMed ID: 33896320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide.
    Fowler CJ; Björklund E; Lichtman AH; Naidu PS; Congiu C; Onnis V
    J Enzyme Inhib Med Chem; 2013 Feb; 28(1):172-82. PubMed ID: 22225576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors.
    Deplano A; Cipriano M; Moraca F; Novellino E; Catalanotti B; Fowler CJ; Onnis V
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):562-576. PubMed ID: 30688118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.
    Holt S; Paylor B; Boldrup L; Alajakku K; Vandevoorde S; Sundström A; Cocco MT; Onnis V; Fowler CJ
    Eur J Pharmacol; 2007 Jun; 565(1-3):26-36. PubMed ID: 17397826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen.
    Cipriano M; Björklund E; Wilson AA; Congiu C; Onnis V; Fowler CJ
    Eur J Pharmacol; 2013 Nov; 720(1-3):383-90. PubMed ID: 24120370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor.
    Gouveia-Figueira S; Karlsson J; Deplano A; Hashemian S; Svensson M; Fredriksson Sundbom M; Congiu C; Onnis V; Fowler CJ
    PLoS One; 2015; 10(9):e0139212. PubMed ID: 26406890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fatty acid amide hydrolase and cyclooxygenase-inhibitory properties of novel amide derivatives of carprofen.
    Deplano A; Karlsson J; Fowler CJ; Onnis V
    Bioorg Chem; 2020 Aug; 101():104034. PubMed ID: 32599361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel propanamides as fatty acid amide hydrolase inhibitors.
    Deplano A; Morgillo CM; Demurtas M; Björklund E; Cipriano M; Svensson M; Hashemian S; Smaldone G; Pedone E; Luque FJ; Cabiddu MG; Novellino E; Fowler CJ; Catalanotti B; Onnis V
    Eur J Med Chem; 2017 Aug; 136():523-542. PubMed ID: 28535469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of the N-(3-Methylpyridin-2-yl)amide Derivatives of Flurbiprofen and Ibuprofen with FAAH: Enantiomeric Selectivity and Binding Mode.
    Karlsson J; Morgillo CM; Deplano A; Smaldone G; Pedone E; Luque FJ; Svensson M; Novellino E; Congiu C; Onnis V; Catalanotti B; Fowler CJ
    PLoS One; 2015; 10(11):e0142711. PubMed ID: 26565710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage.
    Sasso O; Migliore M; Habrant D; Armirotti A; Albani C; Summa M; Moreno-Sanz G; Scarpelli R; Piomelli D
    FASEB J; 2015 Jun; 29(6):2616-27. PubMed ID: 25757568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Molecular Basis for Dual Fatty Acid Amide Hydrolase (FAAH)/Cyclooxygenase (COX) Inhibition.
    Palermo G; Favia AD; Convertino M; De Vivo M
    ChemMedChem; 2016 Jun; 11(12):1252-8. PubMed ID: 26593700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors.
    Onnis V; Congiu C; Björklund E; Hempel F; Söderström E; Fowler CJ
    J Med Chem; 2010 Mar; 53(5):2286-98. PubMed ID: 20143779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ
    Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of endocannabinoid metabolism by the metabolites of ibuprofen and flurbiprofen.
    Karlsson J; Fowler CJ
    PLoS One; 2014; 9(7):e103589. PubMed ID: 25061885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen.
    Holt S; Nilsson J; Omeir R; Tiger G; Fowler CJ
    Br J Pharmacol; 2001 Jun; 133(4):513-20. PubMed ID: 11399668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.
    Migliore M; Habrant D; Sasso O; Albani C; Bertozzi SM; Armirotti A; Piomelli D; Scarpelli R
    Eur J Med Chem; 2016 Feb; 109():216-37. PubMed ID: 26774927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors.
    Wilt S; Kodani S; Valencia L; Hudson PK; Sanchez S; Quintana T; Morisseau C; Hammock BD; Kandasamy R; Pecic S
    Bioorg Med Chem; 2021 Dec; 51():116507. PubMed ID: 34794001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, spectroscopic characterization, molecular docking and theoretical studies (DFT) of N-(4-aminophenylsulfonyl)-2-(4-isobutylphenyl) propanamide having potential enzyme inhibition applications.
    Asghar A; Yousuf M; Mubeen H; Nazir R; Haruna K; Onawole AT; Rasheed L
    Bioorg Med Chem; 2019 Jun; 27(12):2397-2404. PubMed ID: 30683553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of phenoxyacyl-ethanolamides and their effects on fatty acid amide hydrolase activity.
    Faure L; Nagarajan S; Hwang H; Montgomery CL; Khan BR; John G; Koulen P; Blancaflor EB; Chapman KD
    J Biol Chem; 2014 Mar; 289(13):9340-51. PubMed ID: 24558037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.